CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 138 filers reported holding CARA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baird Financial Group, Inc. | 33,042 | $93,509 | 0.00% |
| CITIGROUP INC | 58,942 | $166,806 | 0.00% |
| Clearstead Advisors, LLC | 200 | $566 | 0.00% |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 84,378 | $414,296 | 0.00% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 327,420 | $926,599 | 0.00% |
| OSAIC HOLDINGS, INC. | 35,651 | $100,890 | 0.00% |
| First Capital Advisors Group, LLC. | 175 | $495 | 0.00% |
| Parallel Advisors, LLC | 89 | $252 | 0.00% |
| Russell Investments Group, Ltd. | 34,039 | $96,329 | 0.00% |
| Versant Capital Management, Inc | 55 | $156 | 0.00% |
| FNY Investment Advisers, LLC | 100 | $0 | 0.00% |
| DEUTSCHE BANK AG\ | 28,987 | $82,033 | 0.00% |
| Horrell Capital Management, Inc. | 200 | $1 | 0.00% |
| Bank of New York Mellon Corp | 189,175 | $535,364 | 0.00% |
| JPMORGAN CHASE & CO | 41,087 | $116,276 | 0.00% |
| SIMPLEX TRADING, LLC | 23,189 | $65 | 0.00% |
| CAPTRUST FINANCIAL ADVISORS | 17,108 | $48,416 | 0.00% |
| Nuveen Asset Management, LLC | 114,384 | $323,707 | 0.00% |
| Invesco Ltd. | 23,955 | $67,793 | 0.00% |
| WOLVERINE TRADING, LLC | 32,200 | $91,770 | 0.00% |
External links
This page lists CARA THERAPEUTICS INC's shareholders in Q2 2023. To view CARA THERAPEUTICS INC's shareholder history, click here.